Abrogation of cholesteryl ester accumulation via enzymatic inhibition or depletion of ACAT1 was identified as a potent therapeutic strategy to intercept cancer progression and tumor metastasis in orthotropic mouse model of pancreatic cancer. The gene discussed is ACAT1; the disease is familial pancreatic carcinoma.